UpHealth Q2 EPS $(1.05) Down From $(0.90) YoY, Sales $37.80M Beat $32.90M Estimate
Portfolio Pulse from Benzinga Newsdesk
UpHealth (NYSE:UPH) reported Q2 losses of $(1.05) per share, a 16.67% decrease YoY. However, the company's quarterly sales of $37.80 million beat the analyst consensus estimate of $32.90 million by 14.89%, despite being a 13.44% decrease from the same period last year.
August 10, 2023 | 8:22 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
UpHealth reported a YoY decrease in Q2 losses and beat sales estimates, despite a YoY decrease in sales.
While UpHealth's losses have deepened YoY, the company managed to beat sales estimates. However, sales have decreased compared to the same period last year. This mixed result could lead to neutral short-term price movement.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100